🟢 QNTM is trading 5.4% up today after highlighting its patented MS therapy program

QNTM is trading 5.4% up at $4.12 after receiving positive attention for its multiple sclerosis (MS) therapy program.

• A June 25, 2026, press release highlighted Quantum BioPharma’s first-in-class, patented MS therapy, drawing significant investor focus to the company's clinical pipeline.
• The positive sentiment surrounding the therapy development has lifted the stock price despite a mixed performance across the broader market.